arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Catheter Precision, Inc.

VTAK
$0.27 ▼ -0.05 (-14.21%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
37 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Catheter Precision, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth 202.1%
Op. Margin None
ROIC -22.0%
FCF / Share $-1.28
Trailing P/E
Price / Book 0.1x
FCF Yield
Debt / Equity 0.68
info Valuation on last close. End-of-day price, Aug 7, 2026.

37-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$432.00K
↑ +202.1%
Net Income Profit after all expenses
$-1.68M
↑ +58.4%
Operating Margin Operating profit as % of sales
-232.8%
↑ +16.2%
FCF / Share Free cash flow per share
$-1.28
↓ -514.4%
Long-Term Debt Long-term obligations
$3.08M
↑ +105.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
1
Financial Health
29
Cash Quality
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters